318
Participants
Start Date
December 31, 2013
Primary Completion Date
October 31, 2018
Study Completion Date
January 31, 2019
NovaSure Endometrial Ablation
The NovaSure Endometrial Ablation device consists of a disposable single-use, conformable bipolar electrode array mounted on an expandable frame that can create a confluent lesion on the entire interior surface area of the uterine cavity. The device is inserted transcervically into the uterine cavity, and the sheath is retracted to allow the bipolar electrode array to be deployed and conform to the uterine cavity. The disposable device works in conjunction with a dedicated NovaSure RF (radio frequency) controller to perform customized, global endometrial ablation.
Lyndhurst Clinical Research, Winston-Salem
Physicians Care Clinical Research, LLC, Sarasota
Tennessee Women's Care, Nashville
Chattanooga Medical Research, LLC, Chattanooga
Amy Brenner MD & Associates, LLC, West Chester
Seven Hills Women's Center, Cincinnati
Oakwood Hospital and Medical Center, Dearborn
Saginaw Valley Medical Research Group, LLC, Saginaw
Minnesota Gynecology and Surgery, Edina
Western DuPage Obstetrics and Gynecology, Downers Grove
Westside Women's Care, Arvada
New Horizon Women's Care, Chandler
Bosque Women's Care, Albuquerque
Rockwood Clinic, P.S., Spokane
Lead Sponsor
Hologic, Inc.
INDUSTRY